BV2 cell

SKU:BHC11101230
Best Seller Featured Bulk Pricing Research Validated
Overview
Click light‑blue chips for details

BV2 cell is a cell line (Female). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent, Morphology microglial. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Mouse
Morphology Morphology microglial
Growth Properties Adherent
Tissue Brain
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Options selector
Catalog no. Size
305156 1 cryovial
Field Specification
Species Mouse
BV2 cells are a type of microglial cell line derived from C57BL/6 murine, a widely used laboratory mouse strain for animal experiments. These microglial cells have been immortalized using the J2 retrovirus, which carries the v-raf and v-myc oncogenes, resulting in a stable cell line with unique characteristics. BV2 cells express nuclear v-myc and cytoplasmic v-RAF oncogenes, along with the env gp70 antigen on their surface, contributing to their role in immune responses and inflammation within the brain. One of the critical advantages of BV2 cells is their ability to retain the morphological and functional characteristics of primary microglia, the resident immune cells of the central nervous system, making them an ideal model for studying neurodegeneration and brain inflammation. The role of microglia in neurodegeneration, toxicology, and immunity, particularly in conditions such as Alzheimer's disease, is an ever-growing field in biomedical research. Traditional studies often rely on primary microglia cultures and continuous cell preparations. Using a microglia-like cell line, such as BV2 cells, offers a promising alternative by providing a continuous and reproducible source of microglia. BV2 cells, due to v-raf/v-myc expression, show enhanced metabolism and growth, ideal for research on microglial activation and inflammation. Their expression of specific oncogenes and antigens mirrors macrophages, making them valuable for studying immune responses and disease mechanisms. A recent re-evaluation of mice BV2 microglia cells examined their suitability as a substitute for primary microglia (PM). The response of BV2 cells to lipopolysaccharide was compared with that of microglia in both in vitro and in vivo settings, however, with the upregulation of genes being slightly less pronounced on average. BV2 cells displayed normal regulation of nitric oxide and functional response to IFN-gamma, critical parameters for their interaction with T cells, neurons, and other glial cells such as astrocytes. BV2 cells were also found to stimulate other glial cells effectively, leading to the production of interleukin-6 (IL-6) in astrocytes. This interaction between astrocytes and microglia is crucial for understanding the complex cell-cell interactions and the inflammatory response in the brain, especially in the context of neurodegenerative diseases like Alzheimer's, where proteins such as NAPoe31 and NAPoe41, as well as pathways like the startle response and apoptosis, play significant roles. BV2 cells offer a robust and reliable tool for researchers in microglial biology. Their expression of v-raf/v-myc oncogene products enables them to retain key characteristics of microglia and macrophages. BV2 cells have proven to be a valid substitute for primary microglia in various experimental settings, facilitating research on neurodegeneration, toxicology, immunity, and cell-cell interactions.

SKU:BHC11101230

  • cultureMedium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
  • supplements: Supplement the medium with 10% FBS
  • dissociationReagent: Accutase
  • subculturing: Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium.
  • fluidRenewal: 2 to 3 times per week
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
  1. Maintaining moderate levels of hypochlorous acid promotes neural stem cell proliferation and differentiation in the recovery phase of strokeNeural Regeneration Research| DOI: 10.4103/1673-5374.392889 | PMID: 38886957 | PMC: pmc11433893
  2. Advanced hydrogel mesh platform with neural stem cells and human umbilical vein endothelial cells for enhanced axonal regenerationAPL Bioengineering| DOI: 10.1063/5.0244057 | PMC: pmc11964475
  3. Structure matters: commensal Phocaeicola vulgatus lipopolysaccharide induces attenuated microglial activation and preserves neuronal integrityFrontiers in Cellular Neuroscience| DOI: 10.3389/fncel.2026.1796397 | PMID: 42058701 | PMC: pmc13120944
  4. Olfactory proteomics reveals the capacity of the HDAC1 inhibitor pyroxamide to halt the α-synuclein preformed fibrils-induced damage in nasal epithelial, microglial and dopaminergic neuronal cell linesbioRxiv| DOI: 10.1101/2025.10.02.679944 | PMC: bio_rxiv__2025__10__02__679944
  5. Deep proteomic analysis of microglia reveals fundamental biological differences between model systems.Cell reports| DOI: 10.1016/j.celrep.2024.114908 | PMID: 39460937 | PMC: pm39460937
  6. Furan Acids from Nutmeg and Their Neuroprotective and Anti-neuroinflammatory Activities.Journal of agricultural and food chemistry| DOI: 10.1021/acs.jafc.5c02528 | PMID: 40278862 | PMC: pm40278862
  7. HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer's disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie| DOI: 10.1016/j.biopha.2025.117815 | PMID: 39818099 | PMC: pm39818099
  8. MicroRNA-132 regulates quinolinic acid production in the brain during LPS-induced neuroinflammationFrontiers in Immunology| DOI: 10.3389/fimmu.2025.1644783 | PMC: pmc12417171
  9. MicroRNA-132 regulates quinolinic acid production in the brain during LPS-induced neuroinflammation.Frontiers in immunology| DOI: 10.3389/fimmu.2025.1644783 | PMID: 40934002 | PMC: pm40934002
  10. PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular DegenerationPharmaceuticals| DOI: 10.3390/ph17040517 | PMID: 38675477 | PMC: pmc11053938
  11. Selective, Non-nucleotidic Radiotracer for P2Y 12 Receptors: Design, Synthesis, Characterization, and Imaging of Brain Slices.Journal of medicinal chemistry| DOI: 10.1021/acs.jmedchem.5c00213 | PMID: 40367388 | PMC: pm40367388
  12. N -( p -Coumaroyl) Serotonin Ameliorates LPS-Induced Inflammation in BV2 Microglia via MAPK/NF-κB Inactivation and HO-1/NQO1 UpregulationCurrent Issues in Molecular Biology| PMID: 41751494 | PMC: pmc12939688
  13. New Prenylated Isoflavonoids From Erythrina addisoniae With Anti-Neuroinflammatory Activity via Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells Pathway Suppression.Chemistry & biodiversity| DOI: 10.1002/cbdv.202503261 | PMID: 41503951 | PMC: pm41503951

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider